Faculty

Nazia Rashid

Pharm.D, MS, PhD
Senior Director, Health Economics and Outcomes Research
Acadia Pharmaceuticals Inc

2026 Sessions

Latest Discoveries & Emerging Trends in Psychotic Disorders

Breakthrough research in schizophrenia and other psychotic disorders is shaping the future of treatment, diagnosis, and prevention. This session will provide a fast-paced, research-focused deep dive into the most significant discoveries of the past year, featuring expert analysis alongside selected poster presenters unveiling emerging data. Faculty will discuss the latest advancements, offering insight into how these findings may change the way clinicians approach psychotic disorders.

Poster Presenter

Speaker

Wednesday, September 16 4:30–5:30 PM
Room Great Hall A
Latest Discoveries & Emerging Trends
Faculty

Nazia Rashid

Pharm.D, MS, PhD
Senior Director, Health Economics and Outcomes Research
Acadia Pharmaceuticals Inc
Faculty

Christoph Correll

MD
Clinical Professor of Psychiatry
Zucker School of Medicine at Hofstra/Northwell

Christoph Correll is Professor of Psychiatry at The Zucker School of Medicine at Hofstra/Northwell, New York, USA, and also Professor and Chair of the Department of Child and Adolescent Psychiatry, Charité University Medicine, Berlin, Germany. He completed his medical studies at the Free University of Berlin in Germany, and Dundee University Medical School in Scotland. He is board certified in general psychiatry and child and adolescent psychiatry, having completed both residencies at The Zucker Hillside Hospital, NY. Since 1997, he has been working in New York, USA, and since 2017 he is also working in Germany again.

Dr. Correll focuses on the early identification and treatment of youth and adults with severe mental illness, clinical trials, epidemiology, psychopharmacology, meta-analyses, and physical health in mental health. He has published over 1200 journal articles that have been cited more than 120.000 times, and in 08/2026, his h-index was 170, being >120 in the last 5 years alone. He has received over 40 research awards. Since 2014, the beginning of this metric, he has been listed every year by Clarivate/Web of Science as one of the “most influential scientific minds” and “top 1% cited scientists in the area of psychiatry”. Additionally, he has been holding numerous Expertscape rankings based on the number of publications and citations in the past 10 years, including in 08/2026 being ranked number one among world experts in 10 areas, including “central nervous system agents”, “psychotropic drugs“, “schizophrenia”, “schizophrenia spectrum/other psychotic disorders”, “antipsychotics”, “delayed action preparations” and “weight gain”.

Steering Committee

Ilan Melnick

MD
Chief Medical Officer, Passageway Residences of Dade County,
Passageway Residences of Dade County

Ilan Melnick, MD, is the primary psychiatrist in two outpatient clinics in the Miami, Florida area, as well as a staff psychiatrist and Chief Medical Officer at Passageway Residences of Miami-Dade County. In addition, Dr. Melnick is a staff psychiatrist and Medical Director for Jewish Community Services and performs independent medical and psychiatric evaluations for Miami-Dade County police, fire, transit and aviation departments.

Dr. Melnick received his medical degree in Bayamon, Puerto Rico and went on to do his residency in psychiatry and fellowship in geriatric psychiatry at the University of Miami/Jackson Memorial Hospital.He continues to be involved in education as an Assistant Professor at Florida International University School of medicine. He continues to be involved in education through his role giving grand rounds at major universities and hospitals around the world.

Back to top